Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

DE:7V3 Stock Latest News

Company AnnouncementsCantargia Appoints Nomination Committee Ahead of 2027 AGM3d ago
Cantargia Maintains Buy Rating as Strategic Focus and Upcoming Nadunolimab Catalysts Offset Cut in Price Target to SEK12RatingsCantargia Maintains Buy Rating as Strategic Focus and Upcoming Nadunolimab Catalysts Offset Cut in Price Target to SEK122M ago
Company AnnouncementsCantargia details pipeline and financials in H1 2026 interim report2M ago
Pre-Earnings7V3 Earnings Report this Week: Is It a Buy, Ahead of Earnings?2M ago
Cantargia Raises SEK 75 Million in Undersubscribed Rights Issue and Grants Warrants to Fenja CapitalCompany AnnouncementsCantargia Raises SEK 75 Million in Undersubscribed Rights Issue and Grants Warrants to Fenja Capital4M ago
Company AnnouncementsCantargia Highlights Nadunolimab’s Pancreatic Cancer Potential in Upcoming KOL Call4M ago
RatingsCantargia: Buy Rating Reiterated on Nadunolimab Pipeline Progress and New Lung Nodule Trial; SEK14.00 Price Target Maintained4M ago
Cantargia: Buy Rating Reiterated on Strategic Pipeline Progress and Unchanged $14 Price TargetRatingsCantargia: Buy Rating Reiterated on Strategic Pipeline Progress and Unchanged $14 Price Target5M ago
Company AnnouncementsCantargia AGM Backs Equity Incentives and Expands Capital Raising Mandate5M ago
Company AnnouncementsCantargia Highlights Pipeline Progress in Q1 2026 Interim Report5M ago